Intravenous ports and syringe tips are exposed, easily contaminated, and implicated in contributing to a healthcare-associated infection (HAI) according to published research. Per a 2022 study by the World Health Organization and pending the country where care is provided, 7-15% of patients in acute care hospitals acquire an HAI while in
Intravenous ports and syringe tips are exposed, easily contaminated, and implicated in contributing to a healthcare-associated infection (HAI) according to published research. Per a 2022 study by the World Health Organization and pending the country where care is provided, 7-15% of patients in acute care hospitals acquire an HAI while in the facility’s care; 10% of these patients die each year from such HAIs. In 2007 the Centers for Disease Control stated that catheter-related bloodstream, surgical site, and antibiotic-resistant HAIs cost the U.S. Healthcare system $13 billion and cause 99,000 preventable deaths annually. Additionally the International Organization for Standardization recommends that each of the six physiological systems have their own unique connector to prevent tubing misconnections and wrong-route infusion or injection drug errors.
DoubleLock Healthcare, Inc. has completed the proof-of-concept and is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ which aims to become the new standard-of-care in IV drug delivery by preventing bacterial infection to address this costly HAI issue, delivering 100% compliance with IV port and syring
DoubleLock Healthcare, Inc. has completed the proof-of-concept and is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ which aims to become the new standard-of-care in IV drug delivery by preventing bacterial infection to address this costly HAI issue, delivering 100% compliance with IV port and syringe tip asepsis and preventing tubing misconnections and wrong-route infusion or injection drug errors.
Prototype #11 is shown in the images.
Contact Us to View
Laboratory Results
Protective cover - No Bacteria; Increased Safety - No Needles; Reduced Legal and Care Costs; Time Savings; Ease of Use; Decreased Toxic Drug Vapors and Leakage; Ensures Compliance with IV Port Asepsis - No Alcohol Swabs or Alcohol Impregnated Caps Needed.
Unique connector to prevent tubing misconnections.
View Demonstration Video
Intravenous ports and syringe tips are exposed, easily contaminated, and implicated in contributing to a healthcare-associated infection (HAI) according to published research. Per a 2022 study by the World Health Organization and pending the country where care is provided, 7-15% of patients in acute care hospitals acquire an HAI while in the facility’s care; 10% of these patients die each year from such HAIs. The Centers for Disease Control states that catheter-related bloodstream, surgical site, and antibiotic-resistant HAIs cost the U.S. Healthcare system $13 billion and cause 99,000 preventable deaths annually.
DoubleLock Healthcare, Inc. is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ to address this costly HAI issue, delivering 100% IV port and syringe tip asepsis.
Increased Safety - No Needles; Reduced Legal and Care Costs; Time Savings; Ease of Use; Decreased Toxic Drug Vapors and Leakage; Ensures Compliance with IV Port Asepsis - No Alcohol Swabs or Alcohol Impregnated Caps Needed
This Product Has Not Yet Been Approved by the fda
Copyright © 2023-2024 DoubleLock Healthcare, Inc.™ - All Rights Reserved.
Powered by GoDaddy